500mg Fulvestrant Versus Everolimus Plus Exemestane in MBC Patients Refractory to Previous AI
Clinical trial NCT03695341 · COMPLETED
Trial details
- NCT number
- NCT03695341
- Sponsor
- Fudan University
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-05-14
- Primary completion
- 2019-03-10
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.